You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

axitinib

Showing 26 - 50 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Metastatic Renal Cell Carcinoma Trial in Italy (Axitinib, Nivolumab)

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Brescia, Italy
  • +22 more
Apr 19, 2023

Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Vestibular Schwannomas
  • Axitinib
  • New York, New York
    NYU Langone Medical Center
Nov 24, 2021

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Solitary Fibrous Tumor Trial in Milan (Axitinib)

Completed
  • Solitary Fibrous Tumor
  • Axitinib
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Naazionale dei Tumori
Sep 22, 2021

Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

Recruiting
  • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
  • Selenomethionine (SLM)
  • Axitinib
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Renal Cell Carcinoma Trial in United States (Nivolumab, Axitinib)

Recruiting
  • Renal Cell Carcinoma
  • Baltimore, Maryland
  • +3 more
Nov 16, 2021

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

Not yet recruiting
  • Melanoma Stage IV
  • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
  • +2 more
  • (no location specified)
Sep 27, 2021

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Pembrolizumab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 30, 2021

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Completed
  • Renal Cell Carcinoma
  • Kurume, Fukuoka, Japan
  • +11 more
Feb 22, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Axitinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Axitinib
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Sintilimab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 1, 2021

Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Axitinib)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Axitinib
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Apr 9, 2021

Stage III Prostate Cancer, Stage IV Prostate Cancer Trial in Duarte (drug, procedure, other)

Completed
  • Stage III Prostate Cancer
  • Stage IV Prostate Cancer
  • axitinib
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 8, 2021

NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Non-small Cell Lung Cancer Stage III
  • La Jolla, California
  • +5 more
Aug 12, 2022

Among aRCC Patients on Cabozantinib or Axitinib in England

Completed
  • Renal Cell Carcinoma
  • Slough, United Kingdom
    Ipsen Facility
Jan 29, 2021

Metastatic Renal Cell Carcinoma Trial in Canada, United States (AGS-16C3F, Axitinib)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Tucson, Arizona
  • +25 more
Nov 9, 2021

Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

Completed
Has Results
  • Melanoma
  • +4 more
  • therapeutic conventional surgery
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 30, 2020

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Soft Tissue Sarcoma Trial in United Kingdom (Axitinib)

Completed
  • Soft Tissue Sarcoma
  • Axitinib
  • Aberdeen, Scotland, United Kingdom
  • +12 more
Mar 17, 2021

Renal Cell Carcinoma, Nonclear Cell, Temsirolimus Resistance Trial in Seoul (Axitinib)

Completed
  • Renal Cell Carcinoma
  • +2 more
  • Axitinib
  • Seoul, Korea, Republic of
    Seou National University Hospital
Dec 4, 2020

Clear Cell Renal Cell Carcinoma Trial in Korea, Republic of, United States (X4P-001, axitinib)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +19 more
Sep 20, 2021

Endometriosis, Endometriosis Ovary, Endometriosis Externa Trial in Basel (Linifanib, BIBW2992, Axitinib)

Withdrawn
  • Endometriosis
  • +3 more
  • Linifanib
  • +2 more
  • Basel, Вâlе, Switzerland
    BioGene Pharmaceutical Ltd.
Oct 24, 2021